NCT03903614 (SML) is a NA clinical trial of SML in Developmental Dysgraphia, sponsored by Mary H. Teng.

Who is sponsoring NCT03903614?

NCT03903614 is sponsored by Mary H. Teng.

What drugs are being tested in NCT03903614?

Interventions in NCT03903614: SML, CON.

What condition does NCT03903614 study?

NCT03903614 studies Developmental Dysgraphia.

Is NCT03903614 still recruiting?

NCT03903614 is currently completed. Last updated 9 April 2019.

Last reviewed 2019-04-09 · How we verify

NCT03903614: SML

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sensory Motor Lateralization as Handwriting Intervention in School-Based OT

Completed NA Last updated 9 April 2019

What this trial tests

NA trial testing SML in Developmental Dysgraphia in 16 participants. Completed in 12 June 2013.

Timeline

12 September 2012

Primary endpoint
4 January 2013

12 June 2013

Quick facts

Lead sponsor	Mary H. Teng
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	health services research
Enrollment	16
Start date	12 September 2012
Primary completion	4 January 2013
Estimated completion	12 June 2013

Drugs / interventions tested

Conditions studied

Developmental Dysgraphia — all drugs for Developmental Dysgraphia →

Sponsor

Mary H. Teng

Who can join

Eligibility, any sex, with Developmental Dysgraphia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Children who attend School-Based Occupational Therapy (SBOT) show mixed dominance and a liable decreased in the structural and functional differentiation between the two hemispheres. The lack of right-left disparity has been found to link to mirror invariance, poor spatial organization, fragmentary reversals, and handwriting difficulty. This study intends to find out, whether, Sensory Motor Lateralization (SML), "With" a rightward bias, profits handwriting more than the conventional (CON) "Without".

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03903614 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mary H. Teng
Last refreshed: 9 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03903614.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing